”AI is no longer a ‘Rolls-Royce’ technology only attainable by organizations with significant resources. Today, AI is for all.” Aktana’s Alan Kalton explores how AI is now impacting the Medical Device industry and why breaking down barriers to adoption is crucial to enhancing business operations moving forward. Read the full article here.
“We’re providing our sales team with the cutting-edge tools needed in today’s market to help them be successful.” Endpoints News highlights results from Almirall’s recent deployment of Aktana’s Contextual Intelligence platform, which has taken pre-call planning down from hours to minutes.
Almirall Deploys Aktana’s Contextual Intelligence 360 to Optimize Customer Engagement Almirall, LLC achieves 86% user engagement and a dramatic rise in field rep productivity SAN FRANCISCO, May 4, 2022 (BUSINESSWIRE) – Aktana, the leader in intelligent customer engagement for the global life sciences industry, announced that Almirall, LLC selected its Contextual Intelligence Engine for nationwide rollout across […]
Aktana’s CEO, David Ehrlich, joined David E. Williams on the HealthBiz podcast to talk about his personal connection to the healthcare industry, Aktana’s take on AI, and how Aktana’s advances in contextual intelligence are guiding the life sciences industry through its urgent shift to omnichannel engagement.
The once-upon-a-time hurdles to AI for small to mid-size pharma organizations—cost, tech maturity, and culture—are no longer barriers preventing commercial success. Featuring Vincent Cerio at Almirall, a recent article by Alan Kalton breaks down how new approaches to deploying AI are bringing the cost of ownership down while driving impact, flexibility and accessibility way up.
Aktana’s Jonny Rawlinson shares three tips for designing an omnichannel AI ecosystem that maximizes investments while remaining nimble in today’s dynamic and competitive market. Read the full MedCity News article here.
Aktana’s director of strategic alliances and business development, Jonny Rawlinson, explains how designing an omnichannel AI ecosystem that integrates strategies and tools can maximize commercial success for life sciences companies. Veeva’s vice president of commercial strategy, Andy Fuchs, also weighs in.
When it comes to omnichannel and AI, commercial pharma is ready to step on the gas. Read more in a new article by Pharmaceutical Executive about commercial’s rapidly growing digital maturity featuring insights from Aktana’s co-founder, Derek Choy.
“With the pressure still on pharma to innovate quickly and to adapt business operations for the digital world, the use cases for AI are increasing in stride,” writes Meagan Parrish of PharmaVoice. The publication spoke to Aktana’s Derek Choy and other industry leaders about the promise and acceleration of AI in life sciences.
What can other digitally leading industries teach the life sciences industry about implementing omnichannel? Bruce Carlson outlines 3 key learnings featuring Ganes Kesari of Gramener and Ian Liu of Alorica. Read the Med Ad News article here.